Assistant Professor Patricia Zettler was recently quoted in an article by The Verge titled, “Bioethics experts call on GoFundMe to ban unproven medical treatments.” “Harvard Law professor I. Glenn Cohen, suggests steps GoFundMe may take to upend its “ethical problem.” […]
Assistant professor Patricia Zettler was recently interviewed for a story in S&P Global about FDA candidate Stephen Hahn and his ability to handle political pressure. “Patti Zettler, assistant professor of law at The Ohio State University and a former FDA attorney, […]
Assistant Professor Patricia Zettler was recently quoted in an article by Forbes titled, “Yes, People Can Edit The Genome In Their Garage. Can They Be Regulated?” Her article in the July 5, 2019 issue of Science Magazine titled “Regulating genetic […]
Assistant Professor Patricia Zettler recently co-authored an article in the July 5, 2019 edition of Science magazine titled, “Regulating genetic biohacking.”
Zettler, along with Christi J. Guerrini (Baylor College of Medicine) and Jacob S. Sherkow (New York Law School), discusses the government and private regulations concerning biohacking as well as the outlook moving forward in this area.
Assistant Professor Patricia Zettler was recently featured in an article in Science Magazine titled, “FDA enforcement actions plummet under Trump.”
“FDA’s power to enforce its requirements is an important part of how it achieves its public health mission,” said Zettler, a former FDA attorney. “If FDA is not using that power, it sends a signal that violations will be tolerated.”
Assistant professor Patricia Zettler was recently quoted in an article by Pacific Standard titled, “Does the FDA’s plan to regulate new opioids more strictly go far enough?”
“Some have criticized FDA for over-using guidance,” she said, but companies “often” follow them.
Assistant Professor Patricia Zettler was recently quoted in an article by The New York Times titled, “A Judge Rules Against One Stem-Cell Clinic. There Are Hundreds of Them.”
Zettler called the court ruling “a preliminary but important victory for the F.D.A. and the public health.”